HomeRIGL • NASDAQ
add
Rigel Pharmaceuticals Inc
Previous close
$20.97
Day range
$21.18 - $21.86
Year range
$7.48 - $29.82
Market cap
384.08M USD
Avg Volume
217.29K
P/E ratio
10.36
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 53.33M | 80.58% |
Operating expense | 27.72M | -2.58% |
Net income | 11.45M | 238.79% |
Net profit margin | 21.46 | 176.86% |
Earnings per share | 0.63 | 226.00% |
EBITDA | 13.38M | 303.73% |
Effective tax rate | 0.56% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.10M | 55.60% |
Total assets | 175.97M | 39.09% |
Total liabilities | 157.40M | -0.50% |
Total equity | 18.57M | — |
Shares outstanding | 17.87M | — |
Price to book | 20.16 | — |
Return on assets | 18.79% | — |
Return on capital | 28.66% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 11.45M | 238.79% |
Cash from operations | -893.00K | 82.19% |
Cash from investing | -10.55M | -3,471.25% |
Cash from financing | 484.00K | 119.27% |
Net change in cash | -10.96M | -51.98% |
Free cash flow | -5.31M | -137.23% |
About
Founded
1996
Headquarters
Website
Employees
163
